Grown Rogue International (GRUSF) Times Interest Earned (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Times Interest Earned came in at $0.13 in Q1 2026, down 97.84% year-on-year from $5.99 in Q1 2025, and down 96.38% quarter-over-quarter from $3.58 in Q4 2025.
Grown Rogue International (GRUSF) Times Interest Earned (2009 - 2026) Analysis & Trends
Grown Rogue International's Times Interest Earned history runs 17 years deep, the most recent figure standing at $0.13 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 97.84% year-over-year to $0.13 in Q1 2026; TTM through Mar 2026 was -$1135.3 billion, a 7.2267290720454386e+19% decrease from a year earlier, with the FY2025 full-year figure at -$0.32, down 2540.44% from the prior year.
- Times Interest Earned retreated to $0.13 in Q1 2026 per GRUSF's latest filing, from $3.58 in the prior quarter.
- Across five years, Times Interest Earned topped out at $5549.8 billion in Q2 2025 and bottomed at -$10.34 in Q1 2024.
- The 5-year median for Times Interest Earned is -$2.93 (2025), against an average of $426.9 billion.
- Biggest YoY gain for Times Interest Earned was 346449238728738.75% in 2025; the steepest drop was 41580904.85% in 2025.
- Year by year, Times Interest Earned stood at -$4.24 in 2022, then tumbled by 43.07% to -$6.07 in 2023, then soared by 100.0% to -$0.0 in 2024, then jumped by 50856597.92% to $3.58 in 2025, then tumbled by 96.38% to $0.13 in 2026.
- Per Business Quant, the three latest GRUSF Times Interest Earned figures stand at $0.13 (Q1 2026), $3.58 (Q4 2025), and -$2.93 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 3.58 |
| Sep 30, 2025 | -2.93 |
| Jun 30, 2025 | 5,549.82 Bn |
| Mar 31, 2025 | 5.99 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -1.60 |
| Mar 31, 2024 | -10.34 |
| Oct 31, 2023 | -6.07 |
| Jul 31, 2023 | -4.89 |
| Apr 30, 2023 | -8.79 |
| Jan 31, 2023 | -6.50 |
| Jan 31, 2022 | -4.24 |
| Jul 31, 2021 | -14.65 |
| Apr 30, 2021 | 17.13 |
| Jan 31, 2021 | -115.76 |
| Oct 31, 2020 | -6.00 |
| Jul 31, 2020 | -7.18 |
| Apr 30, 2020 | 8.41 |
| Jan 31, 2020 | -1.97 |